Department of Anesthesiology, Graduate School of Medicine, Gunma University, 3-39-22, Showa-Machi, Maebashi, Gunma, 371-8511, Japan.
J Anesth. 2010 Feb;24(1):81-95. doi: 10.1007/s00540-009-0865-x.
According to the guidelines of the American College of Cardiology/American Heart Association 2006 for perioperative cardiovascular evaluation for non-cardiac surgery, beta-blocker therapy should be considered for high-risk individuals undergoing vascular surgery or high- and intermediate-risk patients undergoing non-cardiac surgery. This guideline might induce physicians to increasingly use beta-blockers in the hope of preventing perioperative cardiac complications. However, beta-blockers have potential beneficial effects outside the prevention of cardiac events. In addition to reducing anesthetic and analgesic requirements during the perioperative period, beta-blockers have neuroprotective effects in patients with brain trauma and possible effectiveness in the management of intraoperative awareness-induced post-traumatic stress disorder. Moreover, intrathecal administration of beta-blockers may have antinociceptive effects. Physicians need to bear in mind the benefits of beta-blockers for purposes other than preventing cardiac events when applied in the perioperative period, and they should be familiar with the pharmacodynamics and risk-benefit ratio with their use. This review focuses on possible extracardiac indications of beta-blockers.
根据美国心脏病学会/美国心脏协会 2006 年非心脏手术围手术期心血管评估指南,对于接受血管手术的高危个体和接受非心脏手术的高风险和中风险患者,应考虑使用β受体阻滞剂。该指南可能促使医生越来越多地使用β受体阻滞剂,以期预防围手术期心脏并发症。然而,β受体阻滞剂在预防心脏事件之外具有潜在的有益作用。除了在围手术期减少麻醉和镇痛需求外,β受体阻滞剂对脑外伤患者具有神经保护作用,并且可能对术中知晓引起的创伤后应激障碍的管理有效。此外,鞘内给予β受体阻滞剂可能具有镇痛作用。当在围手术期使用时,医生需要记住β受体阻滞剂除了预防心脏事件之外的其他用途的益处,并且他们应该熟悉其使用的药效学和风险效益比。这篇综述重点关注β受体阻滞剂可能的心脏外适应证。